TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- China opens draft regulations on data protection to public consultation
- Veteran French physicist elected to Chinese Academy of Sciences
- Former Polish deputy PM praises China's economic rise, growing influence
- HK powers the nation's equestrian development
- Forum hailed for promoting Global South modernization
- Wushu needs more events in GBA, coaches in Macao say
